Helps diagnose acute myocardial infarction. Sold as Technescan Pyp, Phosphotec, Cis-Pyro. Every FDA application for this active ingredient.
As of Nov 16, 2026, FDA lists 3 applications for Technetium Tc-99m Pyrophosphate Kit (sold as Technescan Pyp, Phosphotec, Cis-Pyro), first approved May 28, 1974, with 1 new use approved and 0 published complete response letters.
| Shortage | Status | First posted | Updated |
|---|---|---|---|
| Technetium TC-99M Pyrophosphate Kit Injection | Current | Dec 27, 2023 | Nov 2, 2026 |
| May 28, 1974 | Technescan PypNDA 17538 · New formulation or manufacturer | Curium | 17 | Marketed |
| Oct 20, 1976 | PhosphotecNDA 17680 · New formulation or manufacturer | Bracco | 12 | Discontinued |
| Jun 30, 1987 | Cis-PyroNDA 19039 · New formulation or manufacturer | Sun Pharm Inds Inc | 5 | Marketed |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA